Atopic dermatitis-alleviating effects of lactiplantibacillus plantarum LRCC5195 paraprobiotics through microbiome modulation and safety assessment via genomic characterization and in vitro analysis
Abstract The efficacy of paraprobiotics from Lactiplantibacillus plantarum LRCC5195 (LP5195-P) in alleviating atopic dermatitis (AD) through microbiome modulation and its safety were evaluated in AD-induced mice. Oral administration of LP5195-P to mice for 8 weeks after AD induction was used to inve...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-16102-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849226457710067712 |
|---|---|
| author | Ahyoung Lim Jihye Baek Minju Seo Ki-young Kim Seonghan Kim Woongkwon Kwak Jaeho Lee Jungki Kwak Won-Joo Yoon Wonyong Kim Seokmin Yoon |
| author_facet | Ahyoung Lim Jihye Baek Minju Seo Ki-young Kim Seonghan Kim Woongkwon Kwak Jaeho Lee Jungki Kwak Won-Joo Yoon Wonyong Kim Seokmin Yoon |
| author_sort | Ahyoung Lim |
| collection | DOAJ |
| description | Abstract The efficacy of paraprobiotics from Lactiplantibacillus plantarum LRCC5195 (LP5195-P) in alleviating atopic dermatitis (AD) through microbiome modulation and its safety were evaluated in AD-induced mice. Oral administration of LP5195-P to mice for 8 weeks after AD induction was used to investigate changes in microbiota, immune regulation, and symptoms of dermatitis. Taxonomic analysis of the gut microbiota revealed substantially higher bacterial diversity and abundance in LP5195-P treated group compared to that in negative control. Metabolic analysis revealed significant changes in short-chain fatty acid levels. These microbiome changes correlated with alterations in immune modulation. Furthermore, LP5195-P treatment decreased gene expression related to Treg and Th2 responses in the ileum and skin. Improvements in AD symptoms, including edema and erythema, were observed, and inhibitory effects on histamine release and β-hexosaminidase activity were demonstrated. In conclusion, LP5195-P administration induced a balanced immune response involving gut microbiota and short-chain fatty acids, highlighting its potential as a therapeutic candidate for AD. |
| format | Article |
| id | doaj-art-d13f093f50f7415c872f0f2d2a43c87e |
| institution | Kabale University |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-d13f093f50f7415c872f0f2d2a43c87e2025-08-24T11:19:10ZengNature PortfolioScientific Reports2045-23222025-08-0115111710.1038/s41598-025-16102-5Atopic dermatitis-alleviating effects of lactiplantibacillus plantarum LRCC5195 paraprobiotics through microbiome modulation and safety assessment via genomic characterization and in vitro analysisAhyoung Lim0Jihye Baek1Minju Seo2Ki-young Kim3Seonghan Kim4Woongkwon Kwak5Jaeho Lee6Jungki Kwak7Won-Joo Yoon8Wonyong Kim9Seokmin Yoon10Lotte R&D CenterDepartment of Microbiology, Chung-Ang University College of MedicineLotte R&D CenterDepartment of Microbiology, Chung-Ang University College of MedicineLotte R&D CenterLotte R&D CenterLotte R&D CenterLotte R&D CenterLotte R&D CenterDepartment of Microbiology, Chung-Ang University College of MedicineLotte R&D CenterAbstract The efficacy of paraprobiotics from Lactiplantibacillus plantarum LRCC5195 (LP5195-P) in alleviating atopic dermatitis (AD) through microbiome modulation and its safety were evaluated in AD-induced mice. Oral administration of LP5195-P to mice for 8 weeks after AD induction was used to investigate changes in microbiota, immune regulation, and symptoms of dermatitis. Taxonomic analysis of the gut microbiota revealed substantially higher bacterial diversity and abundance in LP5195-P treated group compared to that in negative control. Metabolic analysis revealed significant changes in short-chain fatty acid levels. These microbiome changes correlated with alterations in immune modulation. Furthermore, LP5195-P treatment decreased gene expression related to Treg and Th2 responses in the ileum and skin. Improvements in AD symptoms, including edema and erythema, were observed, and inhibitory effects on histamine release and β-hexosaminidase activity were demonstrated. In conclusion, LP5195-P administration induced a balanced immune response involving gut microbiota and short-chain fatty acids, highlighting its potential as a therapeutic candidate for AD.https://doi.org/10.1038/s41598-025-16102-5Atopic dermatitisLactiplantibacillus plantarumParaprobioticsGut microbiomeGenome characterizationSafety |
| spellingShingle | Ahyoung Lim Jihye Baek Minju Seo Ki-young Kim Seonghan Kim Woongkwon Kwak Jaeho Lee Jungki Kwak Won-Joo Yoon Wonyong Kim Seokmin Yoon Atopic dermatitis-alleviating effects of lactiplantibacillus plantarum LRCC5195 paraprobiotics through microbiome modulation and safety assessment via genomic characterization and in vitro analysis Scientific Reports Atopic dermatitis Lactiplantibacillus plantarum Paraprobiotics Gut microbiome Genome characterization Safety |
| title | Atopic dermatitis-alleviating effects of lactiplantibacillus plantarum LRCC5195 paraprobiotics through microbiome modulation and safety assessment via genomic characterization and in vitro analysis |
| title_full | Atopic dermatitis-alleviating effects of lactiplantibacillus plantarum LRCC5195 paraprobiotics through microbiome modulation and safety assessment via genomic characterization and in vitro analysis |
| title_fullStr | Atopic dermatitis-alleviating effects of lactiplantibacillus plantarum LRCC5195 paraprobiotics through microbiome modulation and safety assessment via genomic characterization and in vitro analysis |
| title_full_unstemmed | Atopic dermatitis-alleviating effects of lactiplantibacillus plantarum LRCC5195 paraprobiotics through microbiome modulation and safety assessment via genomic characterization and in vitro analysis |
| title_short | Atopic dermatitis-alleviating effects of lactiplantibacillus plantarum LRCC5195 paraprobiotics through microbiome modulation and safety assessment via genomic characterization and in vitro analysis |
| title_sort | atopic dermatitis alleviating effects of lactiplantibacillus plantarum lrcc5195 paraprobiotics through microbiome modulation and safety assessment via genomic characterization and in vitro analysis |
| topic | Atopic dermatitis Lactiplantibacillus plantarum Paraprobiotics Gut microbiome Genome characterization Safety |
| url | https://doi.org/10.1038/s41598-025-16102-5 |
| work_keys_str_mv | AT ahyounglim atopicdermatitisalleviatingeffectsoflactiplantibacillusplantarumlrcc5195paraprobioticsthroughmicrobiomemodulationandsafetyassessmentviagenomiccharacterizationandinvitroanalysis AT jihyebaek atopicdermatitisalleviatingeffectsoflactiplantibacillusplantarumlrcc5195paraprobioticsthroughmicrobiomemodulationandsafetyassessmentviagenomiccharacterizationandinvitroanalysis AT minjuseo atopicdermatitisalleviatingeffectsoflactiplantibacillusplantarumlrcc5195paraprobioticsthroughmicrobiomemodulationandsafetyassessmentviagenomiccharacterizationandinvitroanalysis AT kiyoungkim atopicdermatitisalleviatingeffectsoflactiplantibacillusplantarumlrcc5195paraprobioticsthroughmicrobiomemodulationandsafetyassessmentviagenomiccharacterizationandinvitroanalysis AT seonghankim atopicdermatitisalleviatingeffectsoflactiplantibacillusplantarumlrcc5195paraprobioticsthroughmicrobiomemodulationandsafetyassessmentviagenomiccharacterizationandinvitroanalysis AT woongkwonkwak atopicdermatitisalleviatingeffectsoflactiplantibacillusplantarumlrcc5195paraprobioticsthroughmicrobiomemodulationandsafetyassessmentviagenomiccharacterizationandinvitroanalysis AT jaeholee atopicdermatitisalleviatingeffectsoflactiplantibacillusplantarumlrcc5195paraprobioticsthroughmicrobiomemodulationandsafetyassessmentviagenomiccharacterizationandinvitroanalysis AT jungkikwak atopicdermatitisalleviatingeffectsoflactiplantibacillusplantarumlrcc5195paraprobioticsthroughmicrobiomemodulationandsafetyassessmentviagenomiccharacterizationandinvitroanalysis AT wonjooyoon atopicdermatitisalleviatingeffectsoflactiplantibacillusplantarumlrcc5195paraprobioticsthroughmicrobiomemodulationandsafetyassessmentviagenomiccharacterizationandinvitroanalysis AT wonyongkim atopicdermatitisalleviatingeffectsoflactiplantibacillusplantarumlrcc5195paraprobioticsthroughmicrobiomemodulationandsafetyassessmentviagenomiccharacterizationandinvitroanalysis AT seokminyoon atopicdermatitisalleviatingeffectsoflactiplantibacillusplantarumlrcc5195paraprobioticsthroughmicrobiomemodulationandsafetyassessmentviagenomiccharacterizationandinvitroanalysis |